Search results - 125 results

Intra- and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay.

Results Uterine Cervical Neoplasms Abstract: The implementation of cervical screening based on human papillomavirus (HPV) continues to progress rapidly across countries. Evidence has shown that assays ...

Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework.

specimen handling Uterine Cervical Dysplasia Uterine Cervical Neoplasms Vagina Abstract: The accuracy of high-risk human papillomavirus testing with the Xpert HPV assay on vaginal self-samples was compared ...

Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).

Cervical Cancer Elimination Strategy recommend human papillomavirus (HPV) testing as the primary screening test. However, HPV testing is not widely available in the public healthcare system in Kenya. We ...

Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management.

papillomavirus (HPV) is necessary but not sufficient for cervical cancer development. During cervical carcinogenesis, methylation levels increase across host and HPV DNA. DNA methylation has been proposed as ...

Comparison and validation of metadta for meta-analysis of diagnostic test accuracy studies.

Topics:  Human papillomavirus (HPV) and cervical cancer Papillomavirus humain (PVH) et cancer du col de l'utérus Humaan papillomavirus (hpv) en baarmoederhalskanker Service:  Centre du cancer ...

ESGO Prevention Committee opinion: is a single dose of HPV vaccine good enough?

Publication Type: Peer reviewed scientific article Authors: Kamani, Mustafa Onur; Kyrgiou, Maria; Joura, Elmar; Zapardiel, Ignacio; Grigore, Mihaela; M. Arbyn; Preti, Mario; Planchamp, François; Gultekin, Murat Source: Int J Gynecol Cancer, Volume 33, Iss ...

Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.

Cervical Dysplasia Uterine Cervical Neoplasms Abstract: AIM: The Papilloplex high-risk human papillomavirus (hrHPV) test (Genefirst, Oxford, UK) is a single tube real-time HPV test which provides multiplex ...

HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions.

Uterine Cervical Neoplasms Abstract: In 2017, cervical cancer screening in the Netherlands switched from cytology to human papillomavirus (HPV) testing using the validated PCR-based cobas 4800. Women could ...

IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues.

POLICY Quality Control Uterine Cervical Neoplasms Abstract: We advise that only clinically validated HPV assays which have fulfilled internationally accepted performance criteria be used for primary ...

Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.

EU4H ealth Programme. Health Topics:  Human papillomavirus (HPV) and cervical cancer Papillomavirus humain (PVH) et cancer du col de l'utérus Humaan papillomavirus (hpv) en baarmoederhalskanker ...

QR code

QR code for this page URL